Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MGLL | Q99685 | 9/20 | 0.77 |
| ▸ | FAAH | O00519 | 5/20 | 0.77 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.77 |
| ▸ | LMNA | P02545 | 3/20 | 0.77 |
| ▸ | HTT | P42858 | 2/20 | 0.77 |
| ▸ | RECQL | P46063 | 2/20 | 0.77 |
| ▸ | RAB9A | P51151 | 2/20 | 0.77 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.77 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.77 |
| ▸ | MAPT | P10636 | 2/20 | 0.77 |
| ▸ | NPSR1 | Q6W5P4 | 2/20 | 0.77 |
| ▸ | HSP90AA1 | P07900 | 1/20 | 0.77 |
| ▸ | TLR9 | Q9NR96 | 1/20 | 0.77 |
| ▸ | TP53 | P04637 | 1/20 | 0.77 |
| ▸ | PKM | P14618 | 1/20 | 0.77 |
| ▸ | HPGD | P15428 | 1/20 | 0.77 |
| ▸ | XBP1 | P17861 | 1/20 | 0.77 |
| ▸ | GPR35 | Q9HC97 | 1/20 | 0.77 |
| ▸ | GPR55 | Q9Y2T6 | 1/20 | 0.77 |
| ▸ | PTGS1 | P23219 | 7/20 | 0.63 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL19084204 | 1.00 | MGLL (0.77) | MGLLFAAHALDH1A1LMNAHTT | |
| SCHEMBL3482486 | 1.00 | MGLL (0.77) | MGLLFAAHALDH1A1LMNAHTT | |
| SCHEMBL3482696 | 1.00 | MGLL (0.77) | MGLLFAAHALDH1A1LMNAHTT | |
| SCHEMBL3482661 | 1.00 | MGLL (0.77) | MGLLFAAHALDH1A1LMNAHTT | |
| SCHEMBL2607936 | 1.00 | MGLL (0.77) | MGLLFAAHALDH1A1LMNAHTT | |
| SCHEMBL3482524 | 1.00 | MGLL (0.77) | MGLLFAAHALDH1A1LMNAHTT | |
| SCHEMBL19085941 | 1.00 | MGLL (0.77) | MGLLFAAHALDH1A1LMNAHTT | |
| SCHEMBL3483054 | 0.98 | MGLL (0.76) | MGLLFAAHALDH1A1LMNAHTT | |
| SCHEMBL1554093 | 0.91 | MGLL (0.71) | MGLLFAAHALDH1A1LMNAHTT | |
| SCHEMBL20351983 | 0.88 | MGLL (1.00) | MGLLFAAHALDH1A1LMNAHTT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 171 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4077279-A1 | ADHESIVE PHOTOPROTECTIVE COMPOUNDS AND USES THEREOF | SKINOSIVE (FR) | 2022-10-26 | — | — | EP | claimed |
| US-12514926-B2 | Splicing modulator antibody-drug conjugates and methods of use | EISAI R&D MANAGEMENT CO., LTD. (JP) | 2026-01-06 | — | — | US | disclosed |
| US-12502440-B2 | Cross-linking compounds and methods of use thereof | NORTH CAROLINA STATE UNIVERSITY (US) | 2025-12-23 | — | — | US | disclosed |
| WO-2024074814-A9 | COMPOSITION COMPRISING A FUNCTIONALISED DYE AND A DIALLYLAMINE COMONOMER AND USE THEREOF | SUBLINO LIMITED (GB) | 2025-05-22 | — | — | WO | disclosed |
| US-20250135017-A1 | SPLICING MODULATOR ANTIBODY-DRUG CONJUGATES AND METHODS OF USE | EISAI R&D MANAGEMENT CO., LTD. (JP) | 2025-05-01 | — | — | US | disclosed |
| CN-119405833-A | Splice modulating antibody-drug conjugates and methods of use thereof | 卫材R&D管理有限公司 | 2025-02-11 | — | — | CN | disclosed |
| CN-119405832-A | Splice modulating antibody-drug conjugates and methods of use thereof | 卫材R&D管理有限公司 | 2025-02-11 | — | — | CN | disclosed |
| CN-119405834-A | Splice modulating antibody-drug conjugates and methods of use thereof | 卫材R&D管理有限公司 | 2025-02-11 | — | — | CN | disclosed |
| CN-119405831-A | Splice modulating antibody-drug conjugates and methods of use thereof | 卫材R&D管理有限公司 | 2025-02-11 | — | — | CN | disclosed |
| US-12172986-B2 | Splicing modulator antibody-drug conjugates and methods of use | EISAI R&D MANAGEMENT CO., LTD (JP) | 2024-12-24 | — | — | US | disclosed |
| WO-2003084924-A2 | ELECTRON DONORS, ELECTRON ACCEPTORS AND ADHESION PROMOTERS CONTAINING DISULFIDE | NATIONAL STARCH AND CHEMICAL INVESTMENT HOLDING CORPORATION (US) | 2003-10-16 | — | — | WO | disclosed |
| US-20030191270-A1 | Electron donors, electron acceptors and adhesion promoters containing disulfide | HENKEL AG & CO. KGAA (DE) | 2003-10-09 | — | — | US | disclosed |
| US-6441213-B1 | CURABLE; REDUCING VOLATILE COMPOUNDS | NATIONAL STARCH AND CHEMICAL INVESTMENT HOLDING CORPORATION | 2002-08-27 | — | — | US | disclosed |
| CN-1324907-A | Binding promotor containing silane, amino formate or carbamide and donor or receptor functional group | NAT STARCH CHEM INVEST (US) | 2001-12-05 | — | — | CN | disclosed |
| EP-1156053-A2 | Adhesion promoters which are silanes comprising carbamate- or urea-groups, and a group with donor or acceptor functionality | National Starch and Chemical Investment Holding Corporation (US) | 2001-11-21 | — | — | EP | disclosed |
| US-6075120-A | A HETERODIMERIC PEPTIDE MODULATOR; FOR THE TREATMENT OF ASTHMA; FOR THE TREATMENT OF PAIN; ANTIINFLAMMATORY AGENTS | CORTECH, INC. (US) | 2000-06-13 | — | — | US | disclosed |
| US-5863899-A | ANALGESICS AND ANTIINFLAMMATORY AGENT; A MORPHINE OR DERIVATIVE IS ATTACHED TO BRANDYKININ ANTAGONIST PEPTIDE BY MALEIMIDO OR AMINO ACID ANALOG LINKER | CORTECH, INC. (US) | 1999-01-26 | — | — | US | disclosed |
| EP-0671941-A4 | BRADYKININ ANTAGONISTS. | CORTECH INC (US) | 1996-05-29 | — | — | EP | disclosed |
| EP-0671941-A1 | BRADYKININ ANTAGONISTS | CORTECH, INC. (US) | 1995-09-20 | — | — | EP | disclosed |
| WO-1994011021-A1 | BRADYKININ ANTAGONISTS | CORTECH, INC. (US) | 1994-05-26 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12172986-B2 | Splicing modulator antibody-drug conjugates and methods of use | RBM17, RBM22, SF3B1 | MGLL 4600/4885FAAH 4427/4885ALDH1A1 2080/4885 |
| US-12502440-B2 | Cross-linking compounds and methods of use thereof | AOX1, MTCL3, COL1A1 | MGLL 3659/4885FAAH 832/4885ALDH1A1 74/4885 |
| US-20250135017-A1 | SPLICING MODULATOR ANTIBODY-DRUG CONJUGATES AND METHODS OF USE | RBM17, SNRPE, HNRNPAB | MGLL 4708/4885FAAH 4513/4885ALDH1A1 2079/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.